A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients.

1999127 citationsJournal Article

Authors

Glenn M. Chertow · Brigham and Women's Hospital

Maureen Dillon

Abstract

We conclude that RenaGel and RenaGel with calcium are similarly effective in the treatment of ESRD-related hyperphosphatemia. Provision of supplemental calcium or metabolites of vitamin D with RenaGel may enhance control of hyperparathyroidism.

Topics & Keywords

Parathyroid Disorders and Treatments Biomedical Research and Pathophysiology Genetic Syndromes and Imprinting

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 51, Issue 1, pp. 18-26

Field-Weighted Citation Impact: 6.56